Altimmune, Inc. (ALT)
5.35
-0.08
(-1.38%)
USD |
NASDAQ |
Dec 11, 16:00
5.39
+0.04
(+0.75%)
After-Hours: 18:12
Altimmune Free Cash Flow: -66.66M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viking Therapeutics, Inc. | -224.58M |
| Eli Lilly & Co. | 6.436B |
| Pfizer Inc. | 10.38B |
| Terns Pharmaceuticals, Inc. | -77.99M |
| Rhythm Pharmaceuticals, Inc. | -149.13M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.90M |
| Cash from Investing (Quarterly) | -149.32M |
| Cash from Financing (Quarterly) | 39.35M |
| Free Cash Flow Per Share (Quarterly) | -0.133 |
| Free Cash Flow to Equity (Quarterly) | -11.95M |
| Free Cash Flow to Firm (Quarterly) | -11.40M |
| Free Cash Flow Yield | -15.69% |